CytomX Newsroom

H.C. Wainwright Maintains CytomX(CTMX.US) With Hold Rating

Futu NewsSep 13 18:31

H.C. Wainwright Sticks to Their Hold Rating for CytomX Therapeutics (CTMX)

TipRanksSep 13 18:20

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)

TipRanksAug 22 21:22

CytomX Therapeutics Analyst Ratings

BenzingaAug 22 19:34

H.C. Wainwright Maintains CytomX(CTMX.US) With Hold Rating

Futu NewsAug 22 18:31

CytomX Therapeutics (CTMX) Receives a Buy From Barclays

TipRanksAug 9 15:54

CytomX Therapeutics Analyst Ratings

BenzingaJun 27 18:35

CytomX Therapeutics Analyst Ratings

BenzingaMay 28 17:35

Piper Sandler Upgrades CytomX Therapeutics to Overweight, Raises Price Target to $3.5

BenzingaMay 28 17:35

BMO Capital Maintains Market Perform on CytomX Therapeutics, Raises Price Target to $3.59

BenzingaMay 9 22:55

HC Wainwright & Co. : The CytomX Therapeutics (CTMX.US) neutral rating was reaffirmed.

Zhitong FinanceMay 9 22:10

Wedbush: Upgraded CytomX Therapeutics (CTMX.US) rating from neutral to better than the market rating, and adjusted the target price from $3.00 to $8.00.

Zhitong FinanceMay 9 21:12

CytomX Therapeutics Analyst Ratings

BenzingaMay 9 21:10

Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3

MT NewswiresMay 9 19:51

Barclays Sticks to Its Buy Rating for CytomX Therapeutics (CTMX)

TipRanksMay 9 15:30

CytomX Therapeutics Analyst Ratings

BenzingaMay 6 20:35

Jefferies Upgrades CytomX Therapeutics to Buy, Price Target at $8

MT NewswiresMay 6 19:11

Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Idexx Laboratories (IDXX) and CytomX Therapeutics (CTMX)

TipRanksMay 6 16:41

Buy Rating for CytomX Therapeutics on Promising CX-904 Probody Therapy Prospects

TipRanksMay 6 08:01

CytomX Therapeutics Analyst Ratings

BenzingaMay 2 00:15